Shandong Weigao Blood Purification Products Co., Ltd. (SHA:603014)
35.00
+0.55 (1.60%)
At close: Nov 13, 2026
| Market Cap | 14.62B -18.8% |
| Revenue (ttm) | 5.40B +46.1% |
| Net Income | 1.01B +111.9% |
| EPS | 1.63 +35.1% |
| Shares Out | 417.75M |
| PE Ratio | 21.48 |
| Forward PE | 29.05 |
| Dividend | 0.52 (1.48%) |
| Ex-Dividend Date | Sep 14, 2026 |
| Volume | 4,088,000 |
| Open | 34.18 |
| Previous Close | 34.45 |
| Day's Range | 34.04 - 35.42 |
| 52-Week Range | 28.60 - 43.63 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Oct 31, 2026 |